The Health and Human Services Department is eyeing a major shakeup with big implications for safety-net providers, reports Modern Healthcare.

One potential benefit would be having a single agency managing several prescription drug programs, said Elizabeth Lee, a policy advisor at Advocates for Community Health, which represents community health centers.

CMS handles Medicare outpatient drug price negotiations and Medicare Part B inpatient medication pricing and already regulates duplicate discount restrictions, which occur when 340B providers and state Medicaid programs receive discounts on the same drugs, Lee said. The reorganization could streamline oversight in these areas, she said.

“If moving the program to CMS helps bring accountability and transparency to the program, I think that’s a good thing,” Lee said.